The status of new anticoagulantsBATES, Shannon M; WEITZ, Jeffrey I.British journal of haematology. 2006, Vol 134, Num 1, pp 3-19, issn 0007-1048, 17 p.Article

Emerging anticoagulant drugsBATES, Shannon M; WEITZ, Jeffrey I.Arteriosclerosis, thrombosis, and vascular biology. 2003, Vol 23, Num 9, pp 1491-1500, issn 1079-5642, 10 p.Article

Successful management of acute renal artery thromboembolism by intra-arterial thrombolytic therapy with recombinant tissue plasminogen activatorCHENG, Ben-Chung; KO, Sheung-Fat; CHUANG, Feng-Rong et al.Renal failure. 2003, Vol 25, Num 4, pp 665-670, issn 0886-022X, 6 p.Article

Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatmentTRIPODI, A; DE GROOT, P. G; PENGO, V et al.Journal of internal medicine. 2011, Vol 270, Num 2, pp 110-122, issn 0954-6820, 13 p.Article

New oral anticoagulants in developmentWEITZ, Jeffrey I.Thrombosis and haemostasis. 2010, Vol 103, Num 1, pp 62-70, issn 0340-6245, 9 p.Article

Pregnancy and thrombotic riskJAMES, Andra H.Critical care medicine. 2010, Vol 38, Num 2, issn 0090-3493, S57-S63, SUPArticle

The Perioperative Management of Antithrombotic Therapy : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)DOUKETIS, James D; BERGER, Peter B; DUNN, Andrew S et al.Chest. 2008, Vol 133, Num 6, issn 0012-3692, 299.S-339.S, SUPArticle

Increased risk of arterial thromboembolism after a prior episode of venous thromboembolism: results from the Prevention of REnal and Vascular ENd stage Disease (PREVEND) StudyVAN SCHOUWENBURG, Inge M; GANSEVOORT, Ron T; MAHMOODI, Bakhtawar K et al.British journal of haematology. 2012, Vol 159, Num 2, pp 216-222, issn 0007-1048, 7 p.Article

Thromboembolism in Inflammatory Bowel Disease: An Insidious Association Requiring a High Degree of VigilanceDI FABIO, Francesco; LYKOUDIS, Pavlos; GORDON, Philip H et al.Seminars in thrombosis and hemostasis. 2011, Vol 37, Num 3, pp 220-225, issn 0094-6176, 6 p.Article

Venous Thromboembolism in Pregnancy : Venous thromboembolism: Mechanisms, treatment, and public awarenessJAMES, Andra H.Arteriosclerosis, thrombosis, and vascular biology. 2009, Vol 29, Num 3, pp 326-331, issn 1079-5642, 6 p.Article

Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiencyLUXEMBOURG, Beate; PAVLOVA, Anna; GEISEN, Christof et al.Thrombosis and haemostasis. 2014, Vol 111, Num 2, pp 249-257, issn 0340-6245, 9 p.Article

Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumabTEBBUTT, N. C; MURPHY, F; SHANNON, J et al.Annals of oncology. 2011, Vol 22, Num 8, pp 1834-1838, issn 0923-7534, 5 p.Article

New anticoagulants : beyond heparin, low-molecular-weight heparin and warfarinBATES, Shannon M; WEITZ, Jeffrey I.British journal of pharmacology. 2005, Vol 144, Num 8, pp 1017-1028, issn 0007-1188, 12 p.Article

Arterial thromboembolism in pregnancyWALKER, Isobel D.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 2, pp 297-310, issn 1521-6926, 14 p.Article

New antithrombotics: The impact on global health careMAHAN, Charles E; FANIKOS, John.Thrombosis research. 2011, Vol 127, Num 6, pp 518-524, issn 0049-3848, 7 p.Article

Arterial thromboembolism in the pediatric populationPRICE, Victoria; MASSICOTTE, M. Patricia.Seminars in thrombosis and hemostasis. 2003, Vol 29, Num 6, pp 557-565, issn 0094-6176, 9 p.Article

Acute lower limb ischemia as the initial symptom of acute myeloid leukemiaKAFETZAKIS, Alexandros; FOUNDOULAKIS, Andreas; IOANNOU, Christos V et al.Vascular medicine (London). 2007, Vol 12, Num 3, pp 199-202, issn 1358-863X, 4 p.Article

Peripheral arterial ischemic events in cancer patientsSANON, Saurabh; LENIHAN, Daniel J; MOUHAYAR, Elie et al.Vascular medicine (London). 2011, Vol 16, Num 2, pp 119-130, issn 1358-863X, 12 p.Article

A SERIES OF IMAGES IN LOCALIZED FIBRINOLYTIC TREATMENT FOR A PATIENT WITH ACUTE SUPERIOR MESENTERIC ARTERY THROMBOEMBOLISMYANG, M.-H; KAO, C.-C; HSU, K.-F et al.Acta Clinica Belgica. 2008, Vol 63, Num 5, pp 343-344, issn 0001-5512, 2 p.Article

Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levelsFOLKERINGA, Nienke; COPPENS, Michiel; VEEGER, Nic J. G. M et al.Thrombosis and haemostasis. 2008, Vol 100, Num 1, pp 38-44, issn 0340-6245, 7 p.Article

Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patientsWESTER, Jos P. J; HAAS, Fred J. L. M; BIESMA, Douwe H et al.Intensive care medicine (Print). 2004, Vol 30, Num 10, pp 1927-1934, issn 0342-4642, 8 p.Article

Predictive indicators of deep venous thrombosis and pulmonary arterial thromboembolism in 54 subjects after total knee arthroplasty using multislice computed tomography in logistic regression modelsJIN MIYAGI; FUNABASHI, Nobusada; SUZUKI, Masahiko et al.International journal of cardiology. 2007, Vol 119, Num 1, pp 90-94, issn 0167-5273, 5 p.Article

Intra-Abdominal Venous and Arterial Thromboembolism in Inflammatory Bowel DiseaseDI FABIO, Francesco; OBRAND, Daniel; SATIN, Richard et al.Diseases of the colon & rectum. 2009, Vol 52, Num 2, pp 336-342, issn 0012-3706, 7 p.Article

Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based studyTSAI, H.-T; MARSHALL, J. L; WEISS, S. R et al.Annals of oncology. 2013, Vol 24, Num 6, pp 1574-1579, issn 0923-7534, 6 p.Article

Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomesSCHUTZ, F. A. B; JE, Y; AZZI, G. R et al.Annals of oncology. 2011, Vol 22, Num 6, pp 1404-1412, issn 0923-7534, 9 p.Article